These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38649394)

  • 41. Mutation and expression of TP53 in malignant melanomas.
    Weiss J; Heine M; Arden KC; Körner B; Pilch H; Herbst RA; Jung EG
    Recent Results Cancer Res; 1995; 139():137-54. PubMed ID: 7597286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inheritance of Sinclair swine cutaneous malignant melanoma.
    Tissot RG; Beattie CW; Amoss MS
    Cancer Res; 1987 Nov; 47(21):5542-5. PubMed ID: 3664463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dysbiosis of skin microbiome and gut microbiome in melanoma progression.
    Mekadim C; Skalnikova HK; Cizkova J; Cizkova V; Palanova A; Horak V; Mrazek J
    BMC Microbiol; 2022 Feb; 22(1):63. PubMed ID: 35216552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The regressing thin malignant melanoma: a distinctive lesion with metastatic potential.
    Gromet MA; Epstein WL; Blois MS
    Cancer; 1978 Nov; 42(5):2282-92. PubMed ID: 719608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Melanoblastoma in laboratory minipigs: a model for studying human malignant melanoma].
    Fortýn K; Hruban V; Horák V; Hradecký J; Tichý J
    Vet Med (Praha); 1994; 39(10):597-604. PubMed ID: 7992469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutational dichotomy in desmoplastic malignant melanoma corroborated by multigene panel analysis.
    Jahn SW; Kashofer K; Halbwedl I; Winter G; El-Shabrawi-Caelen L; Mentzel T; Hoefler G; Liegl-Atzwanger B
    Mod Pathol; 2015 Jul; 28(7):895-903. PubMed ID: 25769001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
    Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
    Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas.
    Kannengiesser C; Spatz A; Michiels S; Eychène A; Dessen P; Lazar V; Winnepenninckx V; Lesueur F; Druillennec S; Robert C; van den Oord JJ; Sarasin A; Bressac-de Paillerets B;
    Mol Oncol; 2008 Apr; 1(4):425-30. PubMed ID: 19383316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
    Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
    Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.
    Travnickova J; Wojciechowska S; Khamseh A; Gautier P; Brown DV; Lefevre T; Brombin A; Ewing A; Capper A; Spitzer M; Dilshat R; Semple CA; Mathers ME; Lister JA; Steingrimsson E; Voet T; Ponting CP; Patton EE
    Cancer Res; 2019 Nov; 79(22):5769-5784. PubMed ID: 31582381
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Regression in malignant melanoma. Definition, etiopathogenesis, morphology and differential diagnosis].
    Paredes BE
    Pathologe; 2007 Nov; 28(6):453-63. PubMed ID: 17874109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spectrum of morphologic alterations of regression in cutaneous melanoma--potential for improving disease prognosis.
    Zurac S; Negroiu G; Petrescu S; Andrei R; Tebeica T; Popp C; Musţată R; Neagu M; Constantin C; Solovan C; Chiţu V; Reboşapcă A; Andreescu B; Marinescu I; Stăniceanu F
    Rom J Intern Med; 2012; 50(2):145-53. PubMed ID: 23326958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
    Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
    Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL2RG-deficient minipigs generated via CRISPR/Cas9 technology support the growth of human melanoma-derived tumours.
    Ren J; Yu D; Fu R; An P; Sun R; Wang Z; Guo R; Li H; Zhang Y; Li Z; Yang YG; Li W; Hai T; Hu Z
    Cell Prolif; 2020 Oct; 53(10):e12863. PubMed ID: 32871045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimelanoma antibodies in swine with spontaneously regressing melanoma.
    Cui J; Chen D; Misfeldt ML; Swinfard RW; Bystryn JC
    Pigment Cell Res; 1995 Feb; 8(1):60-3. PubMed ID: 7792256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
    Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
    Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location-dependent patterns of genetic and epigenetic alterations.
    Jurmeister P; Wrede N; Hoffmann I; Vollbrecht C; Heim D; Hummel M; Wolkenstein P; Koch I; Heynol V; Schmitt WD; Thieme A; Teichmann D; Sers C; von Deimling A; Thierauf JC; von Laffert M; Klauschen F; Capper D
    J Pathol; 2022 Jan; 256(1):61-70. PubMed ID: 34564861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas.
    Lowes MA; Bishop GA; Crotty K; Barnetson RS; Halliday GM
    J Invest Dermatol; 1997 Jun; 108(6):914-9. PubMed ID: 9182821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A nine-gene signature predicting clinical outcome in cutaneous melanoma.
    Brunner G; Reitz M; Heinecke A; Lippold A; Berking C; Suter L; Atzpodien J
    J Cancer Res Clin Oncol; 2013 Feb; 139(2):249-58. PubMed ID: 23052696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.